<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR68">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fries</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Shinde</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Stoddard</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Thomas</surname>
    <given-names>DN</given-names>
   </name>
   <name>
    <surname>Kpamegan</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>HX</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Hickman</surname>
    <given-names>SP</given-names>
   </name>
   <name>
    <surname>Piedra</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>GM</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults</article-title>
  <source>Immun Ageing</source>
  <year>2017</year>
  <volume>14</volume>
  <fpage>8</fpage>
  <pub-id pub-id-type="doi">10.1186/s12979-017-0090-7</pub-id>
  <?supplied-pmid 28413427?>
  <pub-id pub-id-type="pmid">28413427</pub-id>
 </element-citation>
</ref>
